We recently traveled to New York City for a State of the Science Summit on Advanced Non–Small Cell Lung Cancer. The meeting, which featured insight from experts from NYU Langone’s Perlmutter Cancer Center, covered a wide array of topics, ranging from surgical techniques, to headway made in immunotherapy, to emerging biomarkers, to diagnostic advancements.
